PS-002: Pioneering Gene Therapy to Transform IgA Nephropathy Treatment

• Update on progress of clinical development of gene therapies for glomerular disease
• Patient perceptions of gene therapy
• Development path for gene therapies in glomerular disease

Speakers:

Fredrik Erlandsson

Chief Medical Officer

Purespring Therapeutics